Annual EPS
-$3.44
-$0.11-3.30%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual earnings per share is -$3.44, with the most recent change of -$0.11 (-3.30%) on April 30, 2024.
- During the last 3 years, KALV annual EPS has fallen by -$1.02 (-42.15%).
- KALV annual EPS is now -149.28% below its all-time high of -$1.38, reached on April 30, 2019.
Performance
KALV EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.91
-$0.04-4.60%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly earnings per share is -$0.91, with the most recent change of -$0.04 (-4.60%) on October 31, 2024.
- Over the past year, KALV quarterly EPS has increased by +$0.16 (+14.95%).
- KALV quarterly EPS is now -1394.25% below its all-time high of -$0.06, reached on April 30, 2018.
Performance
KALV Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$3.69
-$0.11-3.07%
October 31, 2024
Summary
- As of February 8, 2025, KALV TTM earnings per share is -$3.69, with the most recent change of -$0.11 (-3.07%) on October 31, 2024.
- Over the past year, KALV TTM EPS has dropped by -$0.24 (-6.96%).
- KALV TTM EPS is now -276.19% below its all-time high of -$0.98, reached on January 31, 2019.
Performance
KALV TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
KALV EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.3% | +14.9% | -7.0% |
| 3 y3 years | -42.1% | -13.8% | -38.2% |
| 5 y5 years | -149.3% | -175.8% | -109.7% |
KALV EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.1% | at low | -23.0% | +14.9% | -21.8% | +1.3% |
| 5 y | 5-year | -149.3% | at low | -145.9% | +14.9% | -125.0% | +1.3% |
| alltime | all time | -149.3% | +90.2% | -1394.3% | +83.8% | -276.2% | +81.7% |
KalVista Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$0.91(+4.6%) | -$3.69(+3.1%) |
| Jul 2024 | - | -$0.87(-18.7%) | -$3.58(+3.8%) |
| Apr 2024 | -$3.44(+3.3%) | -$1.07(+27.4%) | -$3.45(+9.5%) |
| Jan 2024 | - | -$0.84(+5.0%) | -$3.15(+2.9%) |
| Oct 2023 | - | -$0.80(+8.1%) | -$3.06(-3.2%) |
| Jul 2023 | - | -$0.74(-3.9%) | -$3.16(-6.0%) |
| Apr 2023 | -$3.33(-0.9%) | -$0.77(+2.7%) | -$3.36(-5.9%) |
| Jan 2023 | - | -$0.75(-16.7%) | -$3.57(-4.5%) |
| Oct 2022 | - | -$0.90(-4.3%) | -$3.74(+2.7%) |
| Jul 2022 | - | -$0.94(-4.1%) | -$3.64(+8.3%) |
| Apr 2022 | - | -$0.98(+6.5%) | -$3.36(+10.9%) |
| Apr 2022 | -$3.36(+38.8%) | - | - |
| Jan 2022 | - | -$0.92(+15.0%) | -$3.03(+13.5%) |
| Oct 2021 | - | -$0.80(+21.2%) | -$2.67(+9.0%) |
| Jul 2021 | - | -$0.66(+1.5%) | -$2.45(+2.1%) |
| Apr 2021 | -$2.42(+47.6%) | -$0.65(+16.1%) | -$2.40(+13.2%) |
| Jan 2021 | - | -$0.56(-3.4%) | -$2.12(+1.9%) |
| Oct 2020 | - | -$0.58(-4.9%) | -$2.08(+13.7%) |
| Jul 2020 | - | -$0.61(+64.9%) | -$1.83(+11.6%) |
| Apr 2020 | -$1.64(+18.8%) | -$0.37(-28.8%) | -$1.64(-6.8%) |
| Jan 2020 | - | -$0.52(+57.6%) | -$1.76(+19.7%) |
| Oct 2019 | - | -$0.33(-21.4%) | -$1.47(+8.1%) |
| Jul 2019 | - | -$0.42(-14.3%) | -$1.36(-3.5%) |
| Apr 2019 | -$1.38 | -$0.49(+113.0%) | -$1.41(+43.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | -$0.23(+4.5%) | -$0.98(-21.0%) |
| Oct 2018 | - | -$0.22(-53.2%) | -$1.24(-18.4%) |
| Jul 2018 | - | -$0.47(+671.8%) | -$1.52(-2.6%) |
| Apr 2018 | -$1.53(-65.8%) | -$0.06(-87.6%) | -$1.56(-19.1%) |
| Jan 2018 | - | -$0.49(-2.0%) | -$1.93(-21.9%) |
| Oct 2017 | - | -$0.50(-2.0%) | -$2.47(-23.5%) |
| Jul 2017 | - | -$0.51(+18.6%) | -$3.23(-51.4%) |
| Apr 2017 | -$4.47(-82.9%) | -$0.43(-58.3%) | -$6.64(-31.6%) |
| Jan 2017 | - | -$1.03(-18.3%) | -$9.71(-9.9%) |
| Sep 2016 | - | -$1.26(-67.9%) | -$10.78(-11.5%) |
| Jun 2016 | - | -$3.92(+12.0%) | -$12.18(-12.1%) |
| Apr 2016 | -$26.17(+43.8%) | - | - |
| Mar 2016 | - | -$3.50(+66.7%) | -$13.86(-8.3%) |
| Dec 2015 | -$18.20(-47.9%) | -$2.10(-21.1%) | -$15.12(-12.8%) |
| Sep 2015 | - | -$2.66(-52.5%) | -$17.35(-14.1%) |
| Jun 2015 | - | -$5.60(+17.6%) | -$20.20(+10.8%) |
| Apr 2015 | -$34.94(+184.8%) | - | - |
| Mar 2015 | - | -$4.76(+10.0%) | -$18.24(+12.2%) |
| Dec 2014 | -$12.27(+56.6%) | -$4.33(-21.5%) | -$16.26(+19.6%) |
| Sep 2014 | - | -$5.51(+51.6%) | -$13.59(+68.2%) |
| Jun 2014 | - | -$3.64(+30.8%) | -$8.08(+81.8%) |
| Mar 2014 | - | -$2.78(+66.9%) | -$4.45(+166.9%) |
| Dec 2013 | -$7.83(+176.6%) | -$1.67 | -$1.67 |
| Dec 2012 | -$2.83 | - | - |
FAQ
- What is KalVista Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual EPS year-on-year change?
- What is KalVista Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly EPS year-on-year change?
- What is KalVista Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM EPS year-on-year change?
What is KalVista Pharmaceuticals annual earnings per share?
The current annual EPS of KALV is -$3.44
What is the all time high annual EPS for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual earnings per share is -$1.38
What is KalVista Pharmaceuticals annual EPS year-on-year change?
Over the past year, KALV annual earnings per share has changed by -$0.11 (-3.30%)
What is KalVista Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of KALV is -$0.91
What is the all time high quarterly EPS for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly earnings per share is -$0.06
What is KalVista Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, KALV quarterly earnings per share has changed by +$0.16 (+14.95%)
What is KalVista Pharmaceuticals TTM earnings per share?
The current TTM EPS of KALV is -$3.69
What is the all time high TTM EPS for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM earnings per share is -$0.98
What is KalVista Pharmaceuticals TTM EPS year-on-year change?
Over the past year, KALV TTM earnings per share has changed by -$0.24 (-6.96%)